After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

HEALTH and Child Care minister Douglas Mombeshora has reaffirmed the country’s commitment to advancing HIV research, ...

Let us refresh the old gold Buddhist tale of The Quail and the Net: ldquo;Long ago a flock of quails lived in a forest .

KIGALI, July 17 (Xinhua) -- Health experts are calling on governments around the world to increase funding for HIV research and community-led responses, warning that current funding cuts risk ...

Long-acting injectable PrEP may improve access, protection and adherence, especially for young people and pregnant women, according to Hasina Subedar, a senior technical advisor at South Africa’s ...

The US Senate votes to keep money for the President’s Emergency Plan for Aids Relief from a package of more than $9 billion ...

A new injectable drug known as lenacapavir could change how millions of people across the world and Africa in particular access HIV protective drugs, which historically have hard to come by. Presented ...

The World Health Organisation (WHO) has raised concern over the stagnation of global HIV prevention efforts, announcing ...

TANZANIA is among countries expected to benefit from the upcoming rollout of injectable lenacapavir for HIV prevention, following a landmark recommendation by the World Health Organization (WHO).